Micro Emerging Active

SYNH acciones suben un 72% tras una venta de $8M, participación reducida por Kynam Capital

Puntuación
0,3
Velocidad
▲ 0,0
Artículos
3
Fuentes
1

Resumen

Un artículo pertenece a esta narrativa si discute cambios en las tenencias institucionales de Syndax Pharmaceuticals.

Artículos Relacionados

Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges

Nasdaq · Mar 22, 2026
Mixed

This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a …

Nasdaq · Mar 22, 2026
Mixed

Biotech Stock Up 72% Sees $8 Million Sale, but Here's Why One Fund Still Seems …

Nasdaq · Mar 21, 2026
Neutral

Fuentes

Structure Therapeutics Slides 28% This Year as $6 Million Stake … Nasdaq
This $116 Million Buy Joins a 360% Stock Run and … Nasdaq
Biotech Stock Up 72% Sees $8 Million Sale, but Here's … Nasdaq

Cronología

Última actualización Mar 21, 2026